Metoclopramide intranasal (Nasus Pharma)

N/A

Report date: 2026/01/04 17:56:05

Base Information

Drug NameMetoclopramide intranasal (Nasus Pharma)
Drug Alias NameNS-005
ClassificationSmall molecules
Mechanisms of ActionDopamine receptors antagonists
TargetsDopamine receptors
Therapy Area/IndicationsVomiting
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNasus Pharma
China Registration ClassN/A

Develop Information

Active CompaniesNasus Pharma
Inactive CompaniesN/A
Active IndicationsVomiting
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A